[1] Maclennan CA, Martin LB, Micoli F. Vaccines against invasive Salmonella disease:Current status and future directions[J]. Human Vaccines & Immunotherapeutics, 2014, 10(6):1478-1493.
[2] Sushant S, Rodney C, Thomas FW, et al. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development[J]. Expert Review of Vaccines, 2013, 12(9):1021-1031.
[3] Labrie SJ, Samson JE, Moineau S, et al. Bacteriophage resistance mechanisms[J]. Nature Reviews Microbiology, 2010, 8(5):317-327.
[4] Sarika J, Tulsi DC. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi[J]. J Infect Dev Ctries 2013, 7(11):788-795.
[5] 毛普加, 洪愉, 冯金, 等. 甲型副伤寒沙门氏菌噬菌体PSPA1感染宿主相关基因分析[J]. 医学分子生物学杂志, 2014, 11(2):85-89.
[6] Roucourt B, Chibeu A, Lecoutere E, et al. Homotypic interactions among bacteriophage φKMV early proteins[J]. Archives of virology, 2007, 152:1467-1475.
[7] 原薇薇, 杨杰, 王冬梅, 等. 耐甲氧西林金黄色葡萄球菌PBP2a相互作用蛋白的筛选[J]. 第三军医大学学报, 2010, 32(8):749-753.
[8] Capparelli R, Nunzia N, Marco I, et al. Bacteriophage therapy of Salmonella enterica:a fresh appraisal of bacteriophage therapy[J]. J Infect Dis, 2010, 201(1):52-61.
[9] Shanta, D Surojit, D Utpala M, et al. Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica serovars typhi and paratyphi A blood isolates from Kolkata, India during 2009-2013[J]. PLoS One, 2014, 9(8):e101347.
[10] 李建华. 细菌双杂交系统及其在病原微生物学中的应用[J]. 微生物学免疫学进展, 2006, 34(3):34-39.
[11] Gouzel K, Josette P, Agnes U, et al. A bacterial two-hybrid system based on a reconstituted signa transduction pathwayl[J]. Microbiology, 1998, 95(8):5752-5756.
[12] Turner D, Hezwani M, Nelson S, et al. Characterization of the Salmonella bacteriophage vB_SenS-Ent1[J]. J Gen Virol, 2012, 93(9):2046-2056.
[13] 萨姆布鲁克J, 拉塞尔DW, 黄培堂, 编译. 分子克隆实验指南[M]. 第3版. 北京科学出版社, 2002:512-513. |